Heat shock protein 90α (HSP90AA1) in the core target is often highly expressed in liver cancer and is associated with adverse prognosis [31], and its strong binding to cinnamic acid (−5.7 kcal/mol) may provide new ways to overcome a drug resistant target. This evidence concerns the gene HSP90AA1 and liver cancer.